Whilst MALAT1 has been found to be overexpressed in 14% of breast tumour samples, an alternatively spliced variant of MALAT1 (Δsv-MALAT1) showed decreased expression in a subset of tumours and shows potential as an individual prognostic factor for BC [62]. Here, MALAT1 is linked to neoplasm.